SARCOMA UK
Our mission is to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and to create the treatments of the future. We drive awareness of sarcoma cancer, find answers through funding sarcoma research, provide information and support to anyone affected by sarcoma cancer, campaign for better treatments and to improve standards of care.
Financial health, per its FY2025 accounts
The accounts state that Sarcoma UK reported a surplus of £101,258 for the year ended 31 March 2025, increasing total charity funds to £1,904,765. The trustees confirm that unrestricted reserves of £1,897,204 significantly exceed the stated policy target of approximately £963,000, representing six months of operational costs. The auditor reported no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“We also focus on minimising fundraising costs, with just 26% of our expenditure spent on raising funds, demonstrating the efficiency of our fundraising approach.”
“The Board of Trustees aim to maintain reserves at a level which equates to approximately six months of operational costs including budgeted salary, rent and support costs. This is approximately £963,000 for the forthcoming year.” — page 32
“Sarcoma UK Trustees and close family personally donated and raised £74,531 (2024: £12,966), including funds raised through challenge events such as the London Marathon.” — page 49
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Anjula Thompsonchair
- Alan Abraham
- Dr Aisha Begum Miah
- Dr Fiona Cowie
- Duncan Buchanan
- Gary Michael Davison
- Hristo Anastasov
- Isla Robinson
- Jamie Andrew Ford-Cordes
- Leyla Hayes
- Matthew Treagus
- Michael Christopher Parry
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £4.6m | £4.5m |
| 31/03/2024 | £3.8m | £3.5m |
| 31/03/2023 | £2.9m | £2.9m |
| 31/03/2022 | £2.5m | £2.4m |
| 31/03/2021 | £1.9m | £1.9m |
Common questions
Is SARCOMA UK financially healthy?
Per its FY2025 accounts: The accounts state that Sarcoma UK reported a surplus of £101,258 for the year ended 31 March 2025, increasing total charity funds to £1,904,765. The trustees confirm that unrestricted reserves of £1,897,204 significantly exceed the stated policy target of approximately £963,000, representing six months of operational costs. The auditor reported no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were audited by Sayer Vincent LLP.
Who funds SARCOMA UK?
Funders whose own accounts filings name SARCOMA UK as a grant recipient include BONE CANCER RESEARCH TRUST, THE RANDAL CHARITABLE FOUNDATION, ROBERT LUFF FOUNDATION LIMITED, THE EMMANUEL KAYE FOUNDATION, THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION.
Known funders
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE JOSEPH AND LILIAN SULLY FOUNDATION | 2 | £65k |
| THE ANNANDALE CHARITABLE TRUST | 2 | £64k |
| CECIL PILKINGTON CHARITABLE TRUST | 2 | £60k |
| THE GEORGE CADBURY TRUST (GEORGE HENRY T AND LAURENCE J CADBURY SECTIONS) | 2 | £52k |
| THE LANCASHIRE FOUNDATION | 2 | £28k |
| KESWICK TO BARROW WALK | 2 | £21k |
| THE WILLIE AND MABEL MORRIS CHARITABLE TRUST | 2 | £11k |
| THE JONATHAN TOWLER FOUNDATION | 2 | £7k |
Charities like this
- THE EDWARD SHOWLER FOUNDATION
- CANCER RESEARCH UK
- CANCER SUPPORT UK (CSUK)
- THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
- CHILDREN WITH CANCER UK
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| SARCOMA UK | £4.6m | — | — | above | 26.0% | no doubt |
| THE EDWARD SHOWLER FOUNDATION | £144k | — | 0 | unclear | — | no doubt |
| CANCER RESEARCH UK | £734.8m | — | 380 | above | 22.0% | no doubt |
| CANCER SUPPORT UK (CSUK) | £599k | — | — | unclear | — | no doubt |
| THE CHILDREN'S CANCER AND LEUKAEMIA GROUP | £5.5m | — | — | below | — | no doubt |
| CHILDREN WITH CANCER UK | £17.8m | £130,001 - £140,000 | — | unclear | 20.0% | no doubt |